Nanocell COVID-19 vaccine elicits potent neutralizing response
A new study describes the high level of neutralizing antibodies elicited by a nanocell vaccine against SARS-CoV-2 in vitro, in vivo, and human studies.
Source: news-medical.net
Stay updated with breaking news from T Cell Dependentb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study describes the high level of neutralizing antibodies elicited by a nanocell vaccine against SARS-CoV-2 in vitro, in vivo, and human studies.
A new preprint describes the protective efficacy of memory T-cells developed in response to the viral antigen, which could offer long-term immunity.